Given the complex clinical decision tree for NTM lung disease, what is your best counsel for how to optimize clinical outcomes across the severity range for this increasingly recognized pulmonary infection?

Given the complex clinical decision tree for NTM lung disease, what is your best counsel for how to optimize clinical outcomes across the severity range for this increasingly recognized pulmonary infection?

Given the complex clinical decision tree for NTM lung disease, what is your best counsel for how to optimize clinical outcomes across the severity range for this increasingly recognized pulmonary infection?

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Antonio Catanzaro, MD

Antonio Catanzaro, MD

Professor of Medicine
Previously, Director, Tuberculosis Control
Division of Pulmonary, Critical Care, and Sleep Medicine
UC San Diego School of Medicine
San Diego, California